Difference between revisions of "Oxidative Stress"
| Line 1: | Line 1: | ||
==Introduction== | ==Introduction== | ||
| − | + | Coronary Heart Disease (CHD) is the major mortality cause in the Western Hemisphere. Reinstituting blood flow in the acutely occluded coronary vessel became the standard intervention to prevent Myocardial Infarct (MI) progression. Ever since their conception, thrombolysis, Percutaneous Coronary Intervention (PCI) and Coronary Artery Bypass Grafting (CABG) have been at the forefront of CHD treatment, thus limiting MI size. However, it quickly became apparent that after a period of ischemia, reperfusion itself sets off a cascade of events leading to cell injury. It seems that cellular changes in the ischemic period, prime the cell for a loss of homeostasis once blood flow returns. Generation of reactive oxygen species (ROS) has been found to be the main culprit in both ischemia and reperfusion. Still, the cellular and molecular mechanisms behind this are far from being completely elucidated. Novel insight about this interplay and details about the extent by which each of these players contributes to ischemic-reperfusion injury may allow scientists to devise and design proper interventions that ultimately reduce I/R injury in clinical practice. This article explores the mechanisms behind reactive oxygen species production and possible relevant inhibitors in order to mitigate the effects of ischemia and reperfusion. | |
| − | + | Reactive oxygen species (ROS) are continuously formed in biological systems. ROS comes in common forms such as Superoxide (O2•−). These free radicals wreak havoc on the cell and lead to protein dysfunction, DNA damage, and lipid peroxidation, resulting in apoptosis as a result (3). Any increase in radical production or decrease in the defense against ROS induces oxidative stress. This imbalance between ROS formation and ROS detoxification is believed to be involved in a variety of pathogenic processes, such as ischemia-reperfusion (I/R) injury. Although mammalian cells including cardiomyocytes express endogenous free radical scavenging enzymes, such as superoxide dismutase (SOD), catalase, and glutathione peroxidase, these antioxidative defenses are overwhelmed after ischemia and reperfusion and homeostasis is not maintained (4). During the reperfusion phase following ischemia, production of ROS increases remarkably in complex I and III of the mitochondrial electron transport chain, thus leading to the breakdown of antioxidant systems and generation of rapid and severe damage (3). Hydrogen Peroxide specifically, is thought to be converted to the hydroxyl radical, which is considered to be one of the most highly oxidizing and reactive free radicals (2). This is proposed by many to be produced by the Fenton Reaction (1). | |
[[Spin_Trapping|Spin Trapping Technique]] | [[Spin_Trapping|Spin Trapping Technique]] | ||
Revision as of 21:15, 22 March 2020
Introduction
Coronary Heart Disease (CHD) is the major mortality cause in the Western Hemisphere. Reinstituting blood flow in the acutely occluded coronary vessel became the standard intervention to prevent Myocardial Infarct (MI) progression. Ever since their conception, thrombolysis, Percutaneous Coronary Intervention (PCI) and Coronary Artery Bypass Grafting (CABG) have been at the forefront of CHD treatment, thus limiting MI size. However, it quickly became apparent that after a period of ischemia, reperfusion itself sets off a cascade of events leading to cell injury. It seems that cellular changes in the ischemic period, prime the cell for a loss of homeostasis once blood flow returns. Generation of reactive oxygen species (ROS) has been found to be the main culprit in both ischemia and reperfusion. Still, the cellular and molecular mechanisms behind this are far from being completely elucidated. Novel insight about this interplay and details about the extent by which each of these players contributes to ischemic-reperfusion injury may allow scientists to devise and design proper interventions that ultimately reduce I/R injury in clinical practice. This article explores the mechanisms behind reactive oxygen species production and possible relevant inhibitors in order to mitigate the effects of ischemia and reperfusion.
Reactive oxygen species (ROS) are continuously formed in biological systems. ROS comes in common forms such as Superoxide (O2•−). These free radicals wreak havoc on the cell and lead to protein dysfunction, DNA damage, and lipid peroxidation, resulting in apoptosis as a result (3). Any increase in radical production or decrease in the defense against ROS induces oxidative stress. This imbalance between ROS formation and ROS detoxification is believed to be involved in a variety of pathogenic processes, such as ischemia-reperfusion (I/R) injury. Although mammalian cells including cardiomyocytes express endogenous free radical scavenging enzymes, such as superoxide dismutase (SOD), catalase, and glutathione peroxidase, these antioxidative defenses are overwhelmed after ischemia and reperfusion and homeostasis is not maintained (4). During the reperfusion phase following ischemia, production of ROS increases remarkably in complex I and III of the mitochondrial electron transport chain, thus leading to the breakdown of antioxidant systems and generation of rapid and severe damage (3). Hydrogen Peroxide specifically, is thought to be converted to the hydroxyl radical, which is considered to be one of the most highly oxidizing and reactive free radicals (2). This is proposed by many to be produced by the Fenton Reaction (1).
References
LLoyd, Roger; Hanna, Phillip; Mason, Ronald, The origin of the hydroxyl radical oxygen in the fenton reaction, Free Radical Biology and Medicine, 22, 5, pp 885-888.